These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Biosynthesis and interaction of endothelium-derived vasoactive mediators. Thiemermann C Eicosanoids; 1991; 4(4):187-202. PubMed ID: 1789995 [TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide and nitric oxide-independent relaxing factor in contraction and relaxation of rabbit blood vessels. Fujimoto S; Itoh T Eur J Pharmacol; 1997 Jul; 330(2-3):177-84. PubMed ID: 9253951 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of aclarubicin on nitric oxide production in aortic smooth muscle cells and macrophages. Wakabayashi I; Mayer B; Groschner K Biochem Pharmacol; 2000 Mar; 59(6):719-26. PubMed ID: 10677589 [TBL] [Abstract][Full Text] [Related]
7. Role of the L-arginine-nitric oxide pathway in vascular smooth muscle. Schini VB; Vanhoutte PM Eur Heart J; 1993 Nov; 14 Suppl I():16-21. PubMed ID: 7507437 [TBL] [Abstract][Full Text] [Related]
8. [Elevation of spontaneous tone and effects of antihypertensive treatments in arterial smooth muscle of spontaneously hypertensive rats]. Sunano S; Sasaki F J Smooth Muscle Res; 1993 Aug; 29(4):111-30. PubMed ID: 8136558 [TBL] [Abstract][Full Text] [Related]
10. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485 [TBL] [Abstract][Full Text] [Related]
11. Influence of endothelial mediators on the vascular smooth muscle and circulating platelets and blood cells. Warner TD Int Angiol; 1996 Jun; 15(2):93-9. PubMed ID: 8803631 [TBL] [Abstract][Full Text] [Related]
12. Maintenance of vascular integrity: role of nitric oxide and other bradykinin mediators. Cosentino F; Lüscher TF Eur Heart J; 1995 Nov; 16 Suppl K():4-12. PubMed ID: 8869130 [TBL] [Abstract][Full Text] [Related]
14. Redox Biotransformation and Delivery of Anthracycline Anticancer Antibiotics: How Interpretable Structure-activity Relationships of Lethality Using Electrophilicity and the London Formula for Dispersion Interaction Work. Pang SK Curr Cancer Drug Targets; 2018; 18(6):600-607. PubMed ID: 28359243 [TBL] [Abstract][Full Text] [Related]
15. Profound inhibition of myogenic tone in rat cardiac allografts is due to eNOS- and iNOS-based nitric oxide and an intrinsic defect in vascular smooth muscle contraction. Skarsgard PL; Wang X; McDonald P; Lui AH; Lam EK; McManus BM; van Breemen C; Laher I Circulation; 2000 Mar; 101(11):1303-10. PubMed ID: 10725291 [TBL] [Abstract][Full Text] [Related]
16. Vascular effects of newer cardiovascular drugs: focus on nebivolol and ACE-inhibitors. Lüscher TF; Spieker LE; Noll G; Cosentino F J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S3-11. PubMed ID: 11811390 [TBL] [Abstract][Full Text] [Related]
17. Anthracyclines enhance tension development in cardiac muscle by direct interaction with the contractile system. Bottone AE; de Beer EL; Voest EE J Mol Cell Cardiol; 1997 Mar; 29(3):1001-8. PubMed ID: 9152861 [TBL] [Abstract][Full Text] [Related]
19. The endothelium and control of blood vessel function in health and disease. Schiffrin EL Clin Invest Med; 1994 Dec; 17(6):602-20. PubMed ID: 7895424 [TBL] [Abstract][Full Text] [Related]
20. The treatment of coronary heart disease: an update. Part 3: Statins beyond cholesterol lowering. Kolovou G Curr Med Res Opin; 2001; 17(1):34-7. PubMed ID: 11464443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]